Production plans for EpiVacCorona and KoviVac, two Russian vaccines against coronavirus, have been completed in the first quarter of 2021. This was announced on Monday, April 26, by the Deputy Chairman of the Russian Security Council Dmitry Medvedev.
“According to the production plans, the scale of production is still different, but the plan for the production of EpiVacCorona and KoviVak as a whole has been fulfilled, there is still no absolute result for Sputnik V components, but it is clear that the scale of production is different there,” he is at a meeting on scaling up production and introducing Russian vaccines against COVID-19.
According to Medvedev, the first component of the Sputnik V drug was produced at 89% of the plan, the second – at 65% of the plan. He also noted the challenging conditions in which vaccine manufacturers have had to work in recent months.
At the same time, the Deputy Chairman of the Security Council recalled that the fourth Russian vaccine against coronavirus, Sputnik Light, is currently being registered with the Ministry of Health.
“Its inclusion in the vaccination program will increase the number of citizens who can be vaccinated,” he said.
On the same day, the Minister of Health of Russia Mikhail Murashko announced that registration of the single-component vaccine “Sputnik Light” is planned for the May holidays. In addition, he noted that the country’s Ministry of Health is taking all measures to prevent an increase in the incidence of COVID-19 during and after the May holidays.
Deputy Prime Minister of the Russian Federation Tatyana Golikova said that almost 12 million Russians were vaccinated with the first component of the vaccine against coronavirus infection, and 7.5 million people received both doses of the drug.
Currently, three vaccines against coronavirus are officially registered in Russia – Sputnik V from the Gamaleya Center, EpiVacCorona from the Vector Center and KoviVak from the Chumakov Center. The Ministry of Health assured of the same effectiveness of all three Russian vaccines against coronavirus.